Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The PSP‐associated MAPT H1 subhaplotype in Guadeloupean atypical Parkinsonism

Identifieur interne : 000275 ( France/Analysis ); précédent : 000274; suivant : 000276

The PSP‐associated MAPT H1 subhaplotype in Guadeloupean atypical Parkinsonism

Auteurs : Agnès Camuzat [France] ; Marc Romana ; Alexandra Dürr [France] ; Josué Feingold [France] ; Alexis Brice [France] ; Merle Ruberg [France] ; Annie Lannuzel [France]

Source :

RBID : ISTEX:977337B7AEF3E2B4904C99EFB211D8910E166B28

Descripteurs français

English descriptors

Abstract

The aim of this study was to determine whether the H1 subhaplotype in MAPT associated with progressive supranuclear palsy (PSP) in Caucasians confers risk for PSP‐like atypical parkinsonism in Guadeloupe, a tauopathy. Guadeloupean controls and patients with atypical and idiopathic parkinsonism and ethnically and age‐matched controls were genotyped for H1 and H2 alleles, then for the H1 subhaplotype associated with PSP in Caucasians, using previously described haplotype‐tagging single nucleotide polymorphisms (Ht‐SNPs) in linkage disequilibrium at the MAPT locus. Most Guadeloupean controls and patients were homozygous for the H1 allele; only 5% were heterozygous for the H2 allele, consistent with the European contribution to the racial admixture in Guadeloupe, but equivalent to the frequency found in Caucasian PSP patients. The frequencies of the Ht‐SNPs used to determine the PSP‐associated H1 subhaplotype in both Guadeloupean controls and parkinsonians were similar, indicating that the H1 subhaplotype associated with PSP in Caucasians was not a risk factor for PSP‐like atypical parkinsonism in Guadeloupe. Interestingly, they were also similar to the frequencies in Caucasian PSP patients. The major H1 subhaplotype in Guadeloupe, determined by analysis of linkage desequibrium, differed from the major Caucasian subhaplotype, but corresponded to minor alleles previously described. © 2008 Movement Disorder Society

Url:
DOI: 10.1002/mds.22297


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:977337B7AEF3E2B4904C99EFB211D8910E166B28

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The PSP‐associated MAPT H1 subhaplotype in Guadeloupean atypical Parkinsonism</title>
<author>
<name sortKey="Camuzat, Agnes" sort="Camuzat, Agnes" uniqKey="Camuzat A" first="Agnès" last="Camuzat">Agnès Camuzat</name>
</author>
<author>
<name sortKey="Romana, Marc" sort="Romana, Marc" uniqKey="Romana M" first="Marc" last="Romana">Marc Romana</name>
</author>
<author>
<name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Dürr">Alexandra Dürr</name>
</author>
<author>
<name sortKey="Feingold, Josue" sort="Feingold, Josue" uniqKey="Feingold J" first="Josué" last="Feingold">Josué Feingold</name>
</author>
<author>
<name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
</author>
<author>
<name sortKey="Ruberg, Merle" sort="Ruberg, Merle" uniqKey="Ruberg M" first="Merle" last="Ruberg">Merle Ruberg</name>
</author>
<author>
<name sortKey="Lannuzel, Annie" sort="Lannuzel, Annie" uniqKey="Lannuzel A" first="Annie" last="Lannuzel">Annie Lannuzel</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:977337B7AEF3E2B4904C99EFB211D8910E166B28</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.22297</idno>
<idno type="url">https://api.istex.fr/document/977337B7AEF3E2B4904C99EFB211D8910E166B28/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001A94</idno>
<idno type="wicri:Area/Istex/Curation">001A94</idno>
<idno type="wicri:Area/Istex/Checkpoint">001156</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Camuzat A:the:psp:associated</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:18785640</idno>
<idno type="wicri:Area/PubMed/Corpus">002028</idno>
<idno type="wicri:Area/PubMed/Curation">002028</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002054</idno>
<idno type="wicri:Area/Ncbi/Merge">002335</idno>
<idno type="wicri:Area/Ncbi/Curation">002335</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002335</idno>
<idno type="wicri:Area/Main/Merge">003178</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:09-0058928</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001019</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001D00</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001053</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Camuzat A:the:psp:associated</idno>
<idno type="wicri:Area/Main/Merge">003661</idno>
<idno type="wicri:Area/Main/Curation">002600</idno>
<idno type="wicri:Area/Main/Exploration">002600</idno>
<idno type="wicri:Area/France/Extraction">000275</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">The PSP‐associated MAPT H1 subhaplotype in Guadeloupean atypical Parkinsonism</title>
<author>
<name sortKey="Camuzat, Agnes" sort="Camuzat, Agnes" uniqKey="Camuzat A" first="Agnès" last="Camuzat">Agnès Camuzat</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM, UMR_S 679, Neurology and Experimental Therapeutics, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC Univ Paris 06, UMR_S 679, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Romana, Marc" sort="Romana, Marc" uniqKey="Romana M" first="Marc" last="Romana">Marc Romana</name>
<affiliation>
<wicri:noCountry code="subField">Guadeloupe</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Dürr">Alexandra Dürr</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM, UMR_S 679, Neurology and Experimental Therapeutics, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC Univ Paris 06, UMR_S 679, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Feingold, Josue" sort="Feingold, Josue" uniqKey="Feingold J" first="Josué" last="Feingold">Josué Feingold</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM, UMR_S 679, Neurology and Experimental Therapeutics, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC Univ Paris 06, UMR_S 679, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM, UMR_S 679, Neurology and Experimental Therapeutics, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC Univ Paris 06, UMR_S 679, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC Univ Paris 06, Pitié‐Salpêtrière Medical School, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Département de Génétique et Cytogénétique, AP‐HP, Groupe Hospitalier Pitié‐Salpêtrière, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ruberg, Merle" sort="Ruberg, Merle" uniqKey="Ruberg M" first="Merle" last="Ruberg">Merle Ruberg</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM, UMR_S 679, Neurology and Experimental Therapeutics, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC Univ Paris 06, UMR_S 679, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lannuzel, Annie" sort="Lannuzel, Annie" uniqKey="Lannuzel A" first="Annie" last="Lannuzel">Annie Lannuzel</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM, UMR_S 679, Neurology and Experimental Therapeutics, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC Univ Paris 06, UMR_S 679, Paris</wicri:regionArea>
<placeName>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation>
<wicri:noCountry code="subField">Guadeloupe</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-12-15">2008-12-15</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">16</biblScope>
<biblScope unit="page" from="2384">2384</biblScope>
<biblScope unit="page" to="2391">2391</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">977337B7AEF3E2B4904C99EFB211D8910E166B28</idno>
<idno type="DOI">10.1002/mds.22297</idno>
<idno type="ArticleID">MDS22297</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Case-Control Studies</term>
<term>Chi-Square Distribution</term>
<term>European Continental Ancestry Group</term>
<term>Female</term>
<term>Gene Frequency</term>
<term>Genotype</term>
<term>Guadeloupe (epidemiology)</term>
<term>Humans</term>
<term>Linkage Disequilibrium</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Parkinsonian Disorders (complications)</term>
<term>Parkinsonian Disorders (genetics)</term>
<term>Parkinsonism</term>
<term>Polymorphism</term>
<term>Polymorphism, Single Nucleotide (genetics)</term>
<term>Risk factor</term>
<term>Supranuclear Palsy, Progressive (complications)</term>
<term>Supranuclear Palsy, Progressive (genetics)</term>
<term>atypical parkinsonian syndromes</term>
<term>genetic polymorphism</term>
<term>genetic risk</term>
<term>progressive supranuclear palsy</term>
<term>tau Proteins (classification)</term>
<term>tau Proteins (genetics)</term>
<term>tauopathy</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="classification" xml:lang="en">
<term>tau Proteins</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Guadeloupe</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Parkinsonian Disorders</term>
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Parkinsonian Disorders</term>
<term>Polymorphism, Single Nucleotide</term>
<term>Supranuclear Palsy, Progressive</term>
<term>tau Proteins</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Case-Control Studies</term>
<term>Chi-Square Distribution</term>
<term>European Continental Ancestry Group</term>
<term>Female</term>
<term>Gene Frequency</term>
<term>Genotype</term>
<term>Humans</term>
<term>Linkage Disequilibrium</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Facteur risque</term>
<term>Maladie de Parkinson</term>
<term>Parkinsonisme</term>
<term>Pathologie du système nerveux</term>
<term>Polymorphisme</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The aim of this study was to determine whether the H1 subhaplotype in MAPT associated with progressive supranuclear palsy (PSP) in Caucasians confers risk for PSP‐like atypical parkinsonism in Guadeloupe, a tauopathy. Guadeloupean controls and patients with atypical and idiopathic parkinsonism and ethnically and age‐matched controls were genotyped for H1 and H2 alleles, then for the H1 subhaplotype associated with PSP in Caucasians, using previously described haplotype‐tagging single nucleotide polymorphisms (Ht‐SNPs) in linkage disequilibrium at the MAPT locus. Most Guadeloupean controls and patients were homozygous for the H1 allele; only 5% were heterozygous for the H2 allele, consistent with the European contribution to the racial admixture in Guadeloupe, but equivalent to the frequency found in Caucasian PSP patients. The frequencies of the Ht‐SNPs used to determine the PSP‐associated H1 subhaplotype in both Guadeloupean controls and parkinsonians were similar, indicating that the H1 subhaplotype associated with PSP in Caucasians was not a risk factor for PSP‐like atypical parkinsonism in Guadeloupe. Interestingly, they were also similar to the frequencies in Caucasian PSP patients. The major H1 subhaplotype in Guadeloupe, determined by analysis of linkage desequibrium, differed from the major Caucasian subhaplotype, but corresponded to minor alleles previously described. © 2008 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<settlement>
<li>Paris</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Romana, Marc" sort="Romana, Marc" uniqKey="Romana M" first="Marc" last="Romana">Marc Romana</name>
</noCountry>
<country name="France">
<noRegion>
<name sortKey="Camuzat, Agnes" sort="Camuzat, Agnes" uniqKey="Camuzat A" first="Agnès" last="Camuzat">Agnès Camuzat</name>
</noRegion>
<name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
<name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
<name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
<name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
<name sortKey="Camuzat, Agnes" sort="Camuzat, Agnes" uniqKey="Camuzat A" first="Agnès" last="Camuzat">Agnès Camuzat</name>
<name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Dürr">Alexandra Dürr</name>
<name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Dürr">Alexandra Dürr</name>
<name sortKey="Feingold, Josue" sort="Feingold, Josue" uniqKey="Feingold J" first="Josué" last="Feingold">Josué Feingold</name>
<name sortKey="Feingold, Josue" sort="Feingold, Josue" uniqKey="Feingold J" first="Josué" last="Feingold">Josué Feingold</name>
<name sortKey="Lannuzel, Annie" sort="Lannuzel, Annie" uniqKey="Lannuzel A" first="Annie" last="Lannuzel">Annie Lannuzel</name>
<name sortKey="Lannuzel, Annie" sort="Lannuzel, Annie" uniqKey="Lannuzel A" first="Annie" last="Lannuzel">Annie Lannuzel</name>
<name sortKey="Ruberg, Merle" sort="Ruberg, Merle" uniqKey="Ruberg M" first="Merle" last="Ruberg">Merle Ruberg</name>
<name sortKey="Ruberg, Merle" sort="Ruberg, Merle" uniqKey="Ruberg M" first="Merle" last="Ruberg">Merle Ruberg</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000275 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000275 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:977337B7AEF3E2B4904C99EFB211D8910E166B28
   |texte=   The PSP‐associated MAPT H1 subhaplotype in Guadeloupean atypical Parkinsonism
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024